Prolonged vitamin D intoxication: Presentation, pathogenesis and progress

Internal Medicine Journal

Volumn 43, Issue 10, 2013, Pages 1148-1150

  Bell, D A ^a,b   Crooke, M J ^c   Hay, N ^c   Glendenning, P ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c WELLINGTON HOSPITAL   (New Zealand)

Author keywords

Acute renal injury; Hypercalcaemia; Vitamin D intoxication

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; CREATININE; PARATHYROID HORMONE;

AGED; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CASE REPORT; CREATININE BLOOD LEVEL; DEHYDRATION; DRUG INDUCED DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCALCEMIA; IMMUNOASSAY; KIDNEY INJURY; LIQUID CHROMATOGRAPHY; LONG TERM EXPOSURE; MEDICATION ERROR; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D INTOXICATION; VITAMIN SUPPLEMENTATION;

ACUTE RENAL INJURY; HYPERCALCAEMIA; VITAMIN D INTOXICATION;

ACUTE KIDNEY INJURY; AGED; CHOLECALCIFEROL; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERCALCEMIA; TIME FACTORS;

EID: 84885943780     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12269     Document Type: Article

References (15)

1. Araki T, Holick MF, Alfonso BD, Charlap E, Romero CM, Rizk D etal. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. J Clin Endocrinol Metab 2011; 96: 3603-3608.
2. Lowe H, Cusano NE, Binkley N, Blaner WS, Bilezikian JP. Vitamin D. Toxicity due to a commonly available 'over the counter' remedy from the Dominican Republic. J Clin Endocrinol Metab 2011; 96: 291-295.
3. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856.
4. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85: 6-18.
5. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U etal. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011; 365: 410-421.
6. Dauber A, Nguyen TT, Sochett E, Cole DE, Horst R, Abrams SA etal. Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab 2012; 97: E268-274.
7. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008; 88: 582S-586.
8. Deluca HF, Prahl JM, Plum LA. 1, 25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Arch Biochem Biophys 2011; 505: 226-230.
9. Lawson DE, Sedrani SH, Douglas J. Interrelationships in rats of tissue pools of cholecalciferol and 25-hydroxycholecalciferol formed in u.v. light. Biochem J 1986; 233: 535-540.
10. Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM etal. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012; 196: 686-687.
11. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
12. Glendenning P, Inderjeeth CA. Screening for vitamin D deficiency: defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment. Pathology 2012; 44: 160-165.
13. Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA etal. Serum 25-hydroxyvitamin D levels in vitamin d-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 2009; 45: 870-875.
14. Feldschun M. Compounding in community pharmacy. Aust Prescr 2008; 31: 30-31.
15. Theraputic Goods Administration, TGA business plan 2012-2013. Australia. [Updated 2012 Nov 20, cited 2013 Apr 2]. Available from URL: http://www.tga.gov.au/about/tga-business-plan-1213-02-operating.htm